Cat.#: ACPP-1356
| Despition | GIRK2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1406 | Human Recoverin Protein (AC1406) | 10 µg | inquiry |
| ACPP-1615 | Human CRYBB1 Protein (AC1615) | 5 µg | inquiry |
| ACPP-1253 | Pin1 Blocking Peptide (AC1253) | 250 µg | inquiry |
| ACPP-1511 | Human NMNAT1 Protein (AC1511) | 5 µg | inquiry |
| ACPP-1743 | Human SCG5 Protein (AC1743) | 2 µg | inquiry |
| ACPP-1399 | Human LGALS7 Protein (AC1399) | 2 µg | inquiry |
| ACPP-1486 | Rat VEGF C Protein (AC1486) | 2 µg | inquiry |
| ACPP-1653 | Human CRYM Protein (AC1653) | 2 µg | inquiry |
| ACPP-1692 | Human GLUL Protein (AC1692) | 5 µg | inquiry |
| ACPP-1288 | C9orf72 Blocking Peptide (AC1288) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.